Industrial Starches - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The industrial starches market size was valued at USD 57.27 billion in 2025 and is estimated to grow from USD 59.53 billion in 2026 to reach USD 72.82 billion by 2031, at a CAGR of 4.11% during the forecast period (2026-2031). This report is Segmented by Source (Corn, Tapioca / Cassava, Potato, and More), Type (Native, and Modified), Application (Food and Beverage, Pharmaceutical, Personal Care, and More), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Tonnes).

Global Industrial Starches Market Trends and Insights

Increasing consumption of processed and convenience foods

Urbanization and the increasing prevalence of dual-income households are significantly contributing to the growing consumption of ready-to-eat meals, bakery products, and shelf-stable sauces. These products heavily rely on starches to provide essential properties such as texture, viscosity, and freeze-thaw stability. According to the United States Department of Agriculture, processed food shipments in the Asia-Pacific region have experienced notable growth, with starch-intensive categories like instant noodles and frozen dumplings leading the way in terms of volume. Modified waxy-maize starches are being adopted as a replacement for guar gum in salad dressings due to their ability to endure high-shear mixing and acidic pH levels without causing syneresis, a technical advantage that clean-label brands emphasize in their front-of-pack claims. In Latin America, snack manufacturers are reformulating extruded products by incorporating tapioca starch to achieve a desirable crispness while reducing oil absorption. This approach not only lowers production costs but also aligns with consumer preferences for healthier product options. The shift from traditional home cooking to industrial food preparation has concentrated starch demand among a smaller number of larger buyers. This trend provides formulators with increased negotiating power but also raises expectations for consistent quality, a standard that only top-tier suppliers are equipped to meet effectively at scale.

Shift toward clean-label and natural ingredients

Retailers in North America and Europe are increasingly requiring ingredient lists with fewer than ten components, prompting brands to replace chemically modified starches with native or physically modified alternatives that consumers perceive as minimally processed. According to the annual report released by Ingredion for the year 2025, the demand for clean-label starches has shown remarkable growth, significantly surpassing the overall performance of the starch division. This shift is largely driven by bakery and dairy manufacturers reformulating their products to avoid E-number declarations, which are mandated by the labeling regulations of the European Union. Native tapioca starch is increasingly being used as a substitute for acetylated and hydroxypropylated variants in organic yogurt production. This is because it complies with the certification requirements of the United States Department of Agriculture (USDA) National Organic Program without necessitating additional documentation, thereby streamlining supply chain audits. However, native starches come with certain limitations, such as narrower processing windows, the tendency to retrograde during refrigerated storage, and shear-thinning when subjected to high-speed mixing. These challenges often compel formulators to use higher quantities or combine them with hydrocolloids, which can negatively impact profit margins. Although the European Food Safety Authority conducted a re-evaluation of modified starches in 2024 and found no safety concerns, consumer skepticism remains strong. This ongoing sentiment continues to sustain the premium pricing for "clean" alternatives and drives the adoption of enzyme-based modification methods that do not involve chemical reagents.

Regulatory complexity and variations across food, pharma, and packaging standards

Divergent definitions of "modified starch" create compliance challenges. The United States Food and Drug Administration (FDA) allows enzymatic hydrolysis under the "native" label, while the European Food Safety Authority (EFSA) classifies the same process as a modification requiring E-number disclosure. This discrepancy forces multinational brands to maintain separate formulations and packaging artwork for each market. India's Food Safety and Standards Authority (FSSAI) has introduced draft starch-purity standards that impose stricter heavy-metal residue limits compared to those set by Codex Alimentarius. This compels importers to source starch from mills equipped with ion-exchange purification, a capability available only at a limited number of global facilities. Pharmaceutical starch must comply with United States Pharmacopeia (USP) monograph specifications for microbial limits, residue on ignition, and pH. However, the European Pharmacopoeia enforces stricter tolerances on sulfur dioxide residues, requiring suppliers to either conduct dual production campaigns or forgo access to one of the markets. Additionally, packaging-film converters face uncertainty as the European Union's proposed Packaging and Packaging Waste Regulation deliberates whether starch-polyester blends qualify for composting certification. This decision will significantly influence capital investments in extrusion lines over the next several years.

Other drivers and restraints analyzed in the detailed report include:

• Rise of plant-based and gluten-free product formulations
• Expansion of pharmaceutical sector using starch as binder and disintegrant
• Stringent GMO restrictions on corn-based starches

Segment Analysis

In 2025, corn accounted for 70.54% of industrial starch revenue, driven by the United States Midwest's long-established wet-milling infrastructure and corn's high amylose content, which is advantageous for film-forming applications. However, tapioca and cassava are experiencing the fastest growth among all source segments, with an annual growth rate of 7.82% projected through 2031. Thailand's cassava-starch exports reached 3.2 million metric tons in 2025, an 11% increase, as European food brands sought non-genetically modified organism (non-GMO) certification and a lower water footprint to diversify supply chains heavily reliant on United States corn. Potato starch, while ranking third in volume, commands a 20% to 30% price premium in pharmaceutical excipients due to its phosphate ester groups, which enhance tablet disintegration without chemical modification. This clean-label advantage is being leveraged by generic-drug manufacturers in India.

Wheat starch remains a niche product, primarily used in European paper-coating mills for its fine granule size and low gelatinization temperature. However, volatility in gluten co-product prices, as wheat gluten prices fluctuated by 40% in 2025, has discouraged capacity expansions. The growing preference for cassava is altering trade dynamics. In 2024, Vietnam commissioned two new tapioca-starch plants with a combined annual capacity of 180,000 metric tons, targeting pharmaceutical and biodegradable-film markets where corn's genetically modified organism (GMO) association poses a barrier to market access. Despite its growth, cassava's lower amylose-to-amylopectin ratio limits its application in high-clarity films and retort-stable sauces, where corn and potato starches maintain technical advantages.

Complete Report Scope:

• By Source
  • Corn
  • Tapioca / Cassava
  • Potato
  • Wheat
  • Others
• By Type
  • Native
  • Modified
• By Application
  • Food and Beverage
  • Pharmaceutical
  • Personal Care
  • Paper, Cardboard, and Corrugated Board
  • Textile
  • Animal Feed
  • Chemicals
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Netherlands
    • Poland
    • Belgium
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Indonesia
    • South Korea
    • Thailand
    • Singapore
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • Egypt
    • Morocco
    • Turkey
    • Rest of Middle East and Africa

Geography Analysis

North America accounted for 30.56% of the industrial starch revenue in 2025, driven by the United States Corn Belt's integrated wet-milling complexes, which co-produce high-fructose corn syrup, corn oil, and animal-feed gluten. Ingredion's USD 50 million expansion in Cedar Rapids, completed in February 2025, added 120,000 metric tons of annual corn-starch capacity to cater to pharmaceutical and clean-label food markets, highlighting North America's shift toward higher-margin specialty starch grades. The United States Food and Drug Administration's 2024 excipient traceability guidance is increasing compliance costs for smaller starch producers, consolidating market share among the top four millers capable of investing in electronic batch-record systems and third-party audits. Canada's starch industry remains export-focused, with wheat-starch mills in Saskatchewan supplying United States paper-coating customers. However, the 2025 Canada-United States softwood lumber dispute indirectly impacted starch demand by reducing corrugated-box orders for construction materials.

The Asia-Pacific region is experiencing the fastest growth, with an annual rate of 6.11% projected through 2031. This growth is driven by cassava-starch capacity expansions in Thailand, Indonesia, and Vietnam, increased pharmaceutical tablet production in India, and the adoption of biodegradable packaging in China's e-commerce sector. Thailand's tapioca-starch exports reached 3.2 million metric tons in 2025, with non-GMO (non-genetically modified organism) certification enabling access to European and Japanese food markets that previously relied on United States corn starch. India's starch imports rose by 14% in fiscal 2025 as domestic maize-starch production struggled to meet pharmaceutical demand. The Food Safety and Standards Authority of India is drafting purity standards that could benefit domestic producers once implemented. In China, the biodegradable-packaging mandate, effective January 2025 in 46 cities, is driving the use of starch-polybutylene adipate terephthalate blends in food-delivery containers. However, cost premiums of 40% to 60% over polystyrene are limiting adoption beyond tier-one urban centers.

Europe's industrial starch market is balancing clean-label consumer preferences with the European Union's Packaging and Packaging Waste Regulation, which requires 65% recycled content in plastic packaging by 2030. This regulation is encouraging the use of starch-polyester blends that biodegrade in industrial composting. Germany's potato-starch production declined by 6% in 2025 due to late-blight issues, but the country remains the European Union's largest producer, with Emsland Group and Avebe controlling two-thirds of the region's capacity. The European Food Safety Authority's 2024 re-evaluation of modified starches found no safety concerns. However, clean-label claims on packaging continue to favor native and enzymatically modified starches, putting pressure on margins for acetylated and cross-linked variants.

List of Companies Covered in this Report:

• Cargill Inc.
• Archer Daniels Midland Co.
• Roquette Frères SA
• Tate and Lyle PLC
• Emsland Group
• Agrana Beteiligungs-AG
• Tereos Group
• Sanwa Starch Co., Ltd.
• Grain Processing Corporation
• Altia Plc
• Manildra Group
• Angel Starch and Food Pvt. Ltd
• Japan Corn Starch Co. Ltd
• Universal Starch-Chem Allied Ltd
• Gulshan Polyols Ltd
• GrainCorp Ltd
• Siam Modified Starch Co.
• Vedan International (Holdings) Ltd
• Honest Derivatives Pvt. Ltd
• Avebe U.A.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support